WINDSOR, Conn., Feb. 21, 2017 -- The Polyclinic, a Seattle, Washington based multispecialty group, has selected Meridian Medical Management to provide revenue cycle management and healthcare business analytics services. Meridian Medical Management will deliver its On Premise Revenue Acceleration Program (OP-RAP) and will assume management of The Polyclinic’s existing medical billing operation. The Polyclinic will utilize Meridian’s proprietary robotic process automation suite and the PrecisionBI healthcare analytics engine. The PrecisionBI engine automatically analyzes the medical practice’s data and deploys business intelligence algorithms that increase revenue.
“We are excited and humbled to have a strategic relationship with The Polyclinic,” according to Rob Gontarek, CEO, of Meridian Medical Management. “The Polyclinic’s reputation as the patient’s choice for healthcare speaks to their commitment to quality.”
“The relationship with Meridian Medical Management allows The Polyclinic expanded operational flexibility plus delivers a technology engine that will facilitate growth and business performance,” said Lloyd David, CEO of The Polyclinic.
About The Polyclinic
Founded in 1917, The Polyclinic is made up of more than 200 physicians and advanced practice clinicians, including internal medicine, family medicine, OB/GYN, pediatrics, and more than 30 additional medical and surgical specialties at 12 locations in and around Seattle. The Polyclinic is one of the largest multi-specialty clinics in the Puget Sound region and its mission is to promote the health of its patients through personalized care. For more information visit www.polyclinic.com.
About Meridian Medical Management
Meridian Medical Management, a portfolio company of The Gores Group, is a leading provider of revenue cycle, business intelligence, EMR and system integration services for large, multi-specialty physician groups and academic practice plans. Leveraging over a decade of experience, Meridian’s team of professionals provides revenue cycle performance, business intelligence and practice growth to some of the most prestigious medical groups in the country. For more information, please visit www.m3meridian.com.
For more Information regarding Meridian Medical Management and the Revenue Acceleration Program and other Meridian companies inclusive of PrecisionBI and Origin Healthcare Solutions, follow us on LinkedIn and Twitter.
About The Gores Group
The Gores Group, founded in 1987 by Alec Gores, is a global investment firm focused on acquiring controlling interests in mature and growing businesses which can benefit from the firm’s operating experience and flexible capital base. The firm combines the operational expertise and detailed due diligence capabilities of a strategic buyer with the seasoned M&A team of a traditional financial buyer. Over its 30 year history, The Gores Group has become a leading investor, having demonstrated a reliable track record of creating value in its portfolio companies alongside management. Headquartered in Los Angeles, The Gores Group maintains offices in Boulder, Co., and London. For more information, please visit http://www.gores.com.
Media Contact: Bill Stone EVP Sales & Marketing [email protected]


TSMC Posts Record Q1 2026 Profits Driven by Surging AI Chip Demand
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
Chinese Cars in Europe: Consumer Trust Is Shifting Fast
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
OpenAI Addresses Security Vulnerability in macOS App Certification Process
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
Volkswagen Q1 2026 Sales Decline Amid China and U.S. Market Pressures
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
Jefferies Upgrades Starbucks to Hold as China JV Deal Closes and U.S. Business Shows Signs of Recovery
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion 



